4-(N)-Docosahexaenoyl 2', 2'-difluorodeoxycytidine induces immunogenic cell death in colon and pancreatic carcinoma models as a single agent.

MLA

Hufnagel, Stephanie, et al. “4-(N)-Docosahexaenoyl 2’, 2’-Difluorodeoxycytidine Induces Immunogenic Cell Death in Colon and Pancreatic Carcinoma Models as a Single Agent.” Cancer Chemotherapy and Pharmacology, vol. 89, no. 1, Jan. 2022, pp. 59–69. EBSCOhost, https://doi.org/10.1007/s00280-021-04367-2.

APA

Hufnagel, S., Xu, H., Colemam, M. F., Valdes, S. A., Liu, K. A., Hursting, S. D., & Cui, Z. (2022). 4-(N)-Docosahexaenoyl 2’, 2’-difluorodeoxycytidine induces immunogenic cell death in colon and pancreatic carcinoma models as a single agent. Cancer Chemotherapy and Pharmacology, 89(1), 59–69. https://doi.org/10.1007/s00280-021-04367-2

Chicago

Hufnagel, Stephanie, Haiyue Xu, Michael F Colemam, Solange A Valdes, Kristyn A Liu, Stephen D Hursting, and Zhengrong Cui. 2022. “4-(N)-Docosahexaenoyl 2’, 2’-Difluorodeoxycytidine Induces Immunogenic Cell Death in Colon and Pancreatic Carcinoma Models as a Single Agent.” Cancer Chemotherapy and Pharmacology 89 (1): 59–69. doi:10.1007/s00280-021-04367-2.